IREN Limited (NASDAQ:IREN) experienced a dramatic surge in its stock price, closing Thursday up 30.5% at $38.26, and continuing to climb 6.1% in premarket trading Friday to $40.59. This rally comes as the company announced it has secured contracts for approximately 85% of its AI Cloud run-rate target of over $4 billion by 2026.
The market's enthusiastic response reflects growing confidence in IREN's AI infrastructure strategy, but also highlights the significant gap between contracted run-rate revenue and actual recognized sales. As of Thursday's close, IREN's market capitalization stood at $13.67 billion, roughly four times its projected contracted annualized revenue of about $3.4 billion.
Revenue Conversion Challenge
While the contract wins are impressive, the company's current AI Cloud revenue remains modest. In the latest quarter, AI Cloud generated $33.6 million in revenue, translating to an annualized run rate of $134.4 million. This means the contracted run-rate revenue is more than 25 times the current revenue pace, underscoring the massive execution challenge ahead.
IREN's most recent quarter also revealed the financial strain of this transition. Total revenue reached $144.8 million, with Bitcoin mining contributing $111.2 million, but the company reported a net loss of $247.8 million. The heavy investment in AI infrastructure is clearly impacting profitability in the short term.
Broader Sector Momentum
Thursday's rally was not isolated to IREN. The Nasdaq Composite advanced 2.78%, and a group of five AI-infrastructure peers jumped an average of 22.4%. IREN outperformed this group by 8.1 percentage points, suggesting that while sector momentum played a role, company-specific factors also drove investor enthusiasm.
Peer performance included CoreWeave (NASDAQ:CRWV) up 21.46%, Nebius Group (NASDAQ:NBIS) up 27.14%, Applied Digital (NASDAQ:APLD) up 20.44%, Core Scientific (NASDAQ:CORZ) up 20.39%, and Hut 8 (NASDAQ:HUT) up 22.74%.
Demand and Funding Strength
Co-CEO Daniel Roberts emphasized the strong demand environment, stating that "demand for our capacity exceeds everything we can build." The company's recent contracts, valued at $2.8 billion with an average duration of about four years, include advance payments covering approximately 45% of GPU expenditures. This upfront cash flow provides significant financial runway.
As of June 30, IREN reported estimated cash and equivalents of about $7.6 billion, including $1.7 billion in restricted cash. The company plans to deliver 480 megawatts of AI Cloud capacity in 2026, scaling to 1.2 gigawatts by 2027.
Volatility and Analyst Views
The stock's recent trading has been volatile, with shares declining 20.9% between July 24 and Wednesday before Thursday's rebound brought the five-session return to 3.2%. Trading volume on Thursday reached 72.98 million shares, 1.7 times the average, indicating heightened investor interest.
Analyst price targets reflect a wide range of expectations. Gautam Chhugani reiterated a Buy rating with a $100 price target on Thursday, while the consensus among 12 analysts stands at $75.18, with the lowest estimate at $46. This dispersion highlights the uncertainty surrounding IREN's ability to convert its ambitious contracts into sustainable revenue.
Risks and Outlook
Investors should note that run-rate revenue is an operational metric, not recognized accounting revenue. The company's targets depend on successful delivery of 480 megawatts by year-end, with actual revenue subject to commissioning, utilization, pricing, and customer acceptance risks.
Looking ahead, the U.S. macroeconomic calendar is packed for next week, with manufacturing, services, and employment data all holding potential to impact growth-stock values. Key releases include the ISM Manufacturing PMI on August 3, job openings data on August 4, ISM Services PMI on August 5, and the July employment report on August 7.
IREN has reinforced its demand narrative, but the company still faces the challenge of execution. Investors are now watching closely to see if contracted run-rate revenue can translate into recognized sales, a critical test for the stock's valuation.
